Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study.
Palhano-Fontes F, Cavalcanti-Ribeiro P, da Costa Gonçalves KT, de Almeida VRN, Barbosa DC, de Araújo Ferreira MA, Bolcont R, De Souza LCAM, Santos NC, Lopes EITC, de Medeiros Lima NB, de Brito AJC, Falchi-Carvalho M, Arcoverde E, Araujo D, Galvão-Coelho NL.
Palhano-Fontes F, et al. Among authors: de brito ajc.
J Affect Disord. 2025 Jan 15;369:155-163. doi: 10.1016/j.jad.2024.09.141. Epub 2024 Sep 26.
J Affect Disord. 2025.
PMID: 39341294
Clinical Trial.